
GSK and Eli Lilly Announce Billions in U.S. Manufacturing Investments Amid Tariff Concerns
Sep 17, 2025 02:38 am UTC| Business Health
GlaxoSmithKline (GSK) and Eli Lilly are making major U.S. manufacturing commitments as global pharmaceutical companies expand domestic operations in response to possible tariffs on imported medicines. According to The Wall...

Syrah Resources Extends Tesla Graphite Supply Agreement Deadline
Sep 17, 2025 02:24 am UTC| Business
Australias Syrah Resources has secured more time to resolve a dispute with Tesla, extending the deadline to address an alleged breach of their critical graphite supply agreement. The new cure date has been moved from...

BHP to Halt Queensland Coal Mine Operations, Cutting 750 Jobs
Sep 17, 2025 01:34 am UTC| Business
BHP, in partnership with Mitsubishi Development, will suspend operations at the Saraji South coking coal mine in Queensland from November 2025, impacting 750 workers. The mine, part of the BHP Mitsubishi Alliance (BMA),...

Orion Minerals Secures Glencore Funding Deal for South African Copper-Zinc Project
Sep 17, 2025 01:31 am UTC| Business
Australias Orion Minerals has signed a non-binding term sheet with Glencore, securing potential funding of $200 million to $250 million for the development of its Prieska copper-zinc project in South Africa. The agreement...

China’s SMIC Trials First Domestic Advanced Chipmaking Equipment for AI Processors
Sep 17, 2025 01:02 am UTC| Technology Business
Semiconductor Manufacturing International Corp (HK:0981), Chinas largest chipmaker, is conducting trials on the countrys first domestically built advanced chipmaking equipment, according to the Financial Times. The...

China Backs TikTok Deal as U.S. Ownership Talks Advance
Sep 17, 2025 01:00 am UTC| Politics Business Technology
China has welcomed the framework deal to transfer TikToks U.S. assets to American ownership, calling it a win-win move that reflects mutual respect and cooperation. The agreement, reached in Madrid, would shift control of...

Akeso Secures U.S. Orphan Drug Status for Cancer Therapy Ligufalimab
Sep 16, 2025 06:14 am UTC| Business Health
Chinese biotech company Akeso Inc. (HK:9926) announced that its experimental cancer drug ligufalimab (AK117) has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of...